# Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome

> **NCT00198536** · PHASE2,PHASE3 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 159 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** Ecabet 2.83%
- **DRUG:** Ecabet 3.70%
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT00198536
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2013-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198536, "Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00198536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*